(b)(4).The device was not returned for investigation.No return product evaluation could be completed.Ct images were obtained by vsi however, were inconclusive and did not provide any information relevant to the analysis.The device lot history record review indicated no non-conformities related to this lot, therefore, supporting the device met material, assembly, and performance specifications prior to shipment.Based on the information submitted, following a tavr procedure, an 18f manta was deployed for closure in the right common femoral artery.Access was achieved utilizing micropuncture and ultrasound.Access position was unable to be determined due to no angiograms being taken during the procedure.Although, during access, the physician had stuck through the inguinal ligament.Arteriotomy was 7.2mm, with no calcification or tortuosity, with a measured depth of 5mm + 1mm.No issues were encountered advancing or withdrawing the procedural sheaths.Prior to closure, activated clotting time (act) was 360, and heparin and protamine were administered.The manta device was deployed to the measured depth, and hemostasis was achieved after five minutes of manual pressure.Later that evening, the patient was bleeding, developed a pseudo aneurysm, was transferred to surgery, and received an unknown amount of packed red blood cells.A pseudo-aneurysm can go undetected and not cause any complications and can occur because of surgery or trauma; the formation of a pseudoaneurysm does not signify a device failure.The suspected root cause of the pseudo aneurysm may likely be due to user error in utilizing manta in a patient with high access (at or above the inguinal ligament).Due to the location of the manta deployment, it is likely the implant was unable to effectively maintain a seal and the implant became dislodged.The patient recovered and was later discharged home.The ifu warns do not to use if the puncture site is proximal to the inguinal ligament or above the most inferior border of the epigastric artery (iea), as this may result in retroperitoneal bleeding.The following potential adverse events related to the deployment of vascular closure devices include retroperitoneal bleeding, and its consequences, as a result of failed closure in the setting of access above the inguinal ligament or the most inferior border of the epigastric artery (iea).Additionally, procedure requirements listed in the ifu indicate a pre-procedure cta is recommended to assess femoral artery anatomy.
|